U.S. FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump

U.S. FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump

Haaretz

Published

The company said it expects to have does of REGEN-COV2 treatment ready for about 80,000 patients by the end of this month, about 200,000 patients by the first week of January

Full Article